Viewing StudyNCT03304080



Ignite Creation Date: 2024-05-06 @ 10:35 AM
Last Modification Date: 2024-10-26 @ 12:32 PM
Study NCT ID: NCT03304080
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-09-06
First Post: 2017-10-03

Brief Title: Anastrozole Palbociclib Trastuzumab and Pertuzumab in HR-positive HER2-positive Metastatic Breast
Sponsor: Icahn School of Medicine at Mount Sinai
Organization: Icahn School of Medicine at Mount Sinai

Conditions & Keywords Data

Conditions:
Name
Breast Diseases
Breast Neoplasms
Keywords:
Name View
Perjeta View
Breast Neoplasms View
Breast Diseases View
Palbociclib View
Trastuzumab View
Pertuzumab View
Hormone Antagonists View
Anastrozole View
Arimidex View
Ibrance View